Thursday, 23 Jan 2020

You are here

RheumNow Week in Review – 30 September 2016

Dr. Jack Cush Reviews highlights in the news and journals from the past week on

  1. Proteomic analysis of RA gut microbiome shows unique citrulline peptides - gut mucosa may contribute to ACPA in RA.
  2. Indomethacin treatment of mice w/ premalignant lesions shows cancer slowing - PGE2 inhibition results in more CD8 Tcells and IFN
  3. Prime Therapeutics shows Xeljanz discontinuations at 30% by 6mos & 44% at 1 yr. 10% use it before MTX/other DMARDs
  4. Taiwan study of HIV population and risk of autoimmune disease showed higher risk for Sjögrens (SIR=1.64), psoriasis (2.05), SLE (2.59), AIHA (35.06), Uveitis (2.50)
  5. Yale study of Alopecia (areata or universalis) showed 32% of 66 pts improved with tofacitinib 5mg bid after 3 months.
  6. IL-6 inhibitor (PF-04236921) NOT effective in SLE;186 pts RCT- 3 doses same as placebo in SRI-4, BICLA responses
  7. Scleroderma Renal Crisis review: 3-5 yrs after onset; acute rise in BP & creat, oliguria, 1/2 with thrombotic angiopathy
  8. EGPA (Churg-Strauss)157 pts:12y delay in Dx, severe asthma predates systemic symptoms by 12 yrs, asthma worse 3-6mo before Dx
  9. Rates of Septic arthritis increased 43% in UK (5.5-->7.8/100k) over last 15yrs, especially in elderly >75.
  10. Serious infections in RA are related to disease activity. The risk with biologics is most likely in 1st 6mos of use.
  11. RA pts (vs non RA) more likely to get Rx: GI Rxs, Abx, thyroid, tricyclics, asthma/inhaled steroids, PPI, HTN Rxs.
  12. 5 severe PSS patients getting transplants were Rx w/ immunosuppressives; showed improvement in skin & lung function…
  13. NSAIDs Pose a Dose-Related Risk for Heart Failure Hospitalizations
  14. ICD-10 Grace Period Ends October 1st
  15. Anti-Sclerostin Drug Prevents Vertebral Fractures in Post-Menopausal Osteoporosis 
  16. FDA Approves New Amgen Biosimilar for Adalimumab - Amjevita (generically called adalimumab-atto) becomes the fourth biosimilar to be FDA approved 
  17. FDA Approves Stelara for Crohn's Colitis  
  18. Ilaris Gets FDA Approval for Rare Febrile Disorders 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

QD Clinic - "I Don't Know Why I'm Here" Consult

QD Clinic - Lessons from the clinic The Consult that shows up without a cause - and what to do?

CDC: 15% of US Adults are Physically Inactive

All states and territories had more than 15% of adults who were physically inactive and this estimate ranged from 17.3 to 47.7%,  according to new state maps of adult physical inactivity prevalence released today by the Centers for Disease Control and Prevention (CDC).

RheumNow Podcast- The Down Side of Steroids (1.17.20)

Dr. Jack Cush reviews the journal reports and news from Be sure to register for RheumNow Live 3/13/2020 in Fort Worth

RheumNow Podcast- Knee Pain Knockout (1.10.20)

Dr. Jack Cush reviews the news and journal reports from this past week on The podcast covers: best therapies for dactylitis and enthesitis; we have a new knockout for knee pain in OA; and are you on the naughty or nice list when it comes to the new ACR-AF guidelines for arthritis? This and more. Tune in.

2019 Rheumatology Year in Review

2019 was a year marked by major advances, hallmark research, and big news items affecting rheumatology.   Herein you will find our top 10 list, formulated by what I think rheumatologists should know and what will likely change their standards and practice in 2020 and beyond.